Most men starting testosterone therapy notice the first changes within two to three weeks, beginning with shifts in energy, mood, and sexual interest. The full range of effects unfolds over months, not days, with body composition changes taking the longest to appear. Here’s a detailed look at what happens, when it happens, and what to watch for along the way.
The First Few Weeks: Mood, Energy, and Libido
Sexual interest is typically the first noticeable change. Increases in libido, sexual thoughts, and morning erections can begin as early as two to three weeks after starting treatment. Most men report a meaningful uptick in sexual desire by the six-week mark, at which point libido improvements tend to plateau. Erectile quality often follows a similar early trajectory, though reaching full improvement in erection firmness and sexual performance can take three to six months, and in some cases up to a year.
Psychological shifts come almost as quickly. Within three to four weeks, many men notice improved mood, reduced irritability, and a decrease in fatigue. Motivation and sociability tend to tick upward around the 30-day mark. Improvements in anxiety, concentration, and self-confidence have been documented at three weeks in clinical monitoring. If you’re starting testosterone partly because of depressive symptoms, expect early relief in the first month or so, but the deepest improvement in depression scores tends to build gradually over 18 to 30 weeks.
Months 3 Through 6: Body Composition Shifts
Changes to muscle and fat take longer because they depend on tissue remodeling, not just hormone signaling. Measurable gains in lean body mass and reductions in fat mass begin appearing around 12 to 16 weeks. Muscle strength follows a similar curve: increases in both upper and lower body strength become demonstrable between 12 and 20 weeks, then continue building toward a peak at 6 to 12 months.
The effect on body fat is particularly striking when combined with a calorie-controlled diet. In one 56-week clinical trial, men on testosterone lost weight almost exclusively from fat, preserving their lean mass, while men on placebo lost a mix of fat and muscle. The testosterone group dropped an additional 2.9 kg of fat mass and nearly 3 percentage points more body fat than the placebo group. They also lost significantly more visceral fat, the deep abdominal fat linked to metabolic disease. During the weight maintenance phase, the testosterone group regained about 3.3 kg of lean mass while the placebo group regained almost none.
These body composition changes can continue marginally for years, but the most dramatic shifts happen in the first 6 to 12 months.
How Different Delivery Methods Compare
Testosterone comes in several forms, and each one behaves a bit differently in your body.
- Injections (cypionate or enanthate): Typically administered weekly or biweekly. Injections produce the highest overall testosterone levels but also the most fluctuation. You may notice energy and mood peaks a day or two after injection, with a dip before the next one. Estrogen conversion tends to be highest with this method.
- Topical gels: Applied daily to the skin. Gels provide more stable day-to-day hormone levels with less estrogen conversion than injections. The tradeoff is the daily routine and the need to avoid skin-to-skin contact with others at the application site until it dries.
- Subcutaneous pellets: Inserted under the skin every few months. Pellets offer convenience but require a minor in-office procedure for placement. Testosterone and estrogen levels fall between those of injections and gels.
All three methods effectively raise testosterone and free testosterone levels within three months, and those increases persist over years of follow-up. The choice between them comes down to your lifestyle preferences, how you respond to each formulation, and your tolerance for specific side effects.
Side Effects to Be Aware Of
The most common side effect of testosterone therapy is an increase in red blood cell production, a condition called erythrocytosis. Your body responds to higher testosterone by making more red blood cells, which thickens the blood and can raise the risk of clotting if left unchecked. The rate of this side effect varies dramatically by delivery method: roughly two-thirds of men on injectable testosterone develop elevated red blood cell counts, compared to about 35% on pellets and 13% on gels. Erythrocytosis also develops faster with injections, appearing on average around 10 months in, versus 14 months with gels and 16 months with pellets.
Some men experience estrogen-related effects. Testosterone is partially converted to estrogen in the body, and when levels climb too high, it can cause breast tenderness or swelling (gynecomastia), water retention, or paradoxically reduced libido. These effects are more common with injections because of the higher peak testosterone levels. If breast symptoms develop, your provider can check estrogen levels and adjust your protocol.
Acne and oily skin are common in the first few months as your body adjusts, particularly if your testosterone dose brings levels to the higher end of the normal range. Most men find this settles down over time.
Fertility: A Critical Consideration
Testosterone therapy suppresses sperm production. This is not a side effect that might happen; it’s an expected physiological consequence. External testosterone signals your brain to stop stimulating the testes, and sperm counts drop to very low levels within about three and a half months in most men. Some men become completely azoospermic, meaning no sperm are detectable at all.
If you plan to have children, this needs to be discussed before starting treatment. Sperm production can recover after stopping testosterone, but recovery is neither instant nor guaranteed to reach prior levels. A pooled analysis of 30 studies found that 67% of men recovered adequate sperm counts within 6 months of stopping, 90% within 12 months, and essentially all within 24 months. Men who were older or had low-normal sperm counts before treatment took longer to recover.
For men who want the benefits of testosterone while preserving fertility, medications that stimulate the testes directly (such as hCG, often combined with other drugs) can help maintain or restore sperm production. In clinical studies, about 96% of men treated with hCG-based regimens recovered spermatogenesis, though the timeline averaged around four to five months.
Blood Work and Ongoing Monitoring
Before starting testosterone, you’ll have baseline blood work drawn, typically including total testosterone (measured in the morning when levels peak), red blood cell counts, and PSA, a prostate marker. Levels of other hormones like LH, FSH, and prolactin help your provider confirm the diagnosis and rule out other causes.
The diagnostic threshold most commonly used is a total testosterone below 300 ng/dL, endorsed by the American Urological Association. Below this level, men tend to experience more symptoms and respond better to treatment.
After starting therapy, expect a follow-up blood draw at three months to confirm your levels are in range and your red blood cell count hasn’t climbed too high. From there, safety labs are typically repeated every six months, with PSA checked at least once a year. These aren’t optional checkups. Monitoring your red blood cell count is the single most important safety measure on testosterone therapy, because elevated counts can be corrected easily (by adjusting dose, switching formulations, or occasionally donating blood) when caught early.
Cardiovascular Safety
For years, concerns lingered about whether testosterone therapy increased heart attack and stroke risk. The most definitive answer came from a large randomized trial published in the New England Journal of Medicine, which found that in men with low testosterone who had preexisting cardiovascular disease or high cardiovascular risk, testosterone therapy was noninferior to placebo for major cardiac events. In plain terms, the treatment group did not have more heart attacks, strokes, or cardiovascular deaths than the placebo group. Earlier studies had produced mixed signals, but the most rigorous recent evidence, including a patient-level meta-analysis, has not confirmed an increased cardiovascular risk.
That said, this safety data applies to men with confirmed testosterone deficiency being treated under medical supervision with appropriate monitoring. It does not extend to supraphysiological doses or unsupervised use.